Global drugmakers' stocks dropped across the board after U.S. President Donald Trump reiterated plans for a "major" tariff on ...

Sun Pharmaceutical Industries Ltd. 524715 shares slid 2.17% to 1,652.10 Indian rupees Wednesday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX ...

Sun Pharmaceutical Industries Ltd. closed 14.89% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

Donald Trump has announced reciprocal tariffs on about 60 countries, including India. He announced 27 per cent reciprocal ...

Sun Pharmaceutical Industries experienced a notable surge in today's session, climbing 2.03% to reach Rs 1786.50. The stock's movement was marked by a significant increase in trading volume ...

Sun Pharma, the largest pharmaceutical company in India, issued one advisory on March 18 cautioning their CFAs and distributors about the rising menace of counterfeit and substandard medicines in the ...

Health Canada sets the bar high, because the new designation means that by doing such testing, qualified labs become part of the pharmaceutical manufacturing chain, where security and documentation ...

Purdue Pharma submitted a new bankruptcy plan Tuesday, which will give its creditors more than $7.4 billion in cash—including up to $7 billion in payments from the billionaire Sackler family ...

Mumbai: In a recent BSE filing, Sun Pharmaceutical Industries Limited has informed that TARO Pharmaceuticals Inc., a subsidiary of Sun Pharmaceutical Industries Limited has completed 100 percent ...

It demands significant resources that are often expensive and inaccessible to biotechnology and pharmaceutical companies of all sizes. Federal regulations like the Current Good Manufacturing ...

LONDON, March 18 (Reuters) - Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff wars, hoping to avert price spikes on top ...

New Delhi: Zydus Pharmaceuticals and Sun Pharma are recalling products in the US market due to manufacturing-related concerns, the US health regulator stated in its latest Enforcement Report. The New ...